Skip to main content

Table 1 Characteristics of 5 HSCT recipients treated with Entecavir

From: Efficacy and tolerability of Entecavir for hepatitis B virus infection after hematopoietic stem cell transplantation

Case

Age (y)

Sex

Disease

Transplantation

GVHD prophylaxis

Steroid administration

cGVHD

Conditioning regimen

Observation period

Sstatus

Cause of death

#1

64

F

MM

Autologous

(−)

No

-

Mel

2 M

Dead

MM

#2

55

F

MDS-RAEB

Allogeneic

FK + MTX

Yes

Yes

BU + CY

9 M

Dead

Aspergillus Pneumonia

#3

24

F

MDS-RCMD

Allogeneic

FK + MTX

Yes

Yes

BU + CY

50 M

Alive

-

#4

58

F

AML

Allogeneic

CsA + MTX

Yes

No

BU + CY

4 M

Dead

Toxoplasmosis

#5

63

F

T-LBL

Allogeneic

FK + MTX

Yes

No

Flu + Mel + TBI(4Gy)

16 M

Alive

-

  1. Abbreviation: MM multiple myeloma, MDS myelodysplastic syndrome, RAEB refractory anemia with excessive blast, RCMD refractory cytopenia with multilineage dysplasia, AML acute myeloid leukemia, T-LBL T lymphoblastic lymphoma, FK tacrolimus, CsA ciclosporin A, Mel melfalan, BU busulfan, CY cyclophosphamide, TBI total body irradiation, Flu fludarabine.